А. С. Колбин

548 total citations
143 papers, 320 citations indexed

About

А. С. Колбин is a scholar working on Epidemiology, Economics and Econometrics and Infectious Diseases. According to data from OpenAlex, А. С. Колбин has authored 143 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Epidemiology, 27 papers in Economics and Econometrics and 21 papers in Infectious Diseases. Recurrent topics in А. С. Колбин's work include Health Systems, Economic Evaluations, Quality of Life (17 papers), Healthcare Systems and Public Health (13 papers) and Pharmaceutical studies and practices (11 papers). А. С. Колбин is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (17 papers), Healthcare Systems and Public Health (13 papers) and Pharmaceutical studies and practices (11 papers). А. С. Колбин collaborates with scholars based in Russia, United States and Lebanon. А. С. Колбин's co-authors include Sidorenko Sv, Н Н Климко, И. И. Дедов, Vladimir Rafalskiy, Marina Kalashnikova, С. Н. Хостелиди, Marina Popova, B. V. Аfanasiev, I Ivanov and N. V. Vasilyeva and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Microbiology and International Journal of Antimicrobial Agents.

In The Last Decade

А. С. Колбин

102 papers receiving 294 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
А. С. Колбин Russia	7	94	62	45	41	36	143	320
Ruibin Wang United States	14	94 1.0×	87 1.4×	33 0.7×	11 0.3×	31 0.9×	35	485
Emily C. Welch United States	7	126 1.3×	21 0.3×	28 0.6×	14 0.3×	69 1.9×	15	356
Leire Leache Spain	10	35 0.4×	43 0.7×	20 0.4×	18 0.4×	13 0.4×	40	278
Robert Tosiello United States	14	267 2.8×	31 0.5×	42 0.9×	16 0.4×	20 0.6×	25	612
Mohamad Sidani United States	8	82 0.9×	36 0.6×	12 0.3×	14 0.3×	35 1.0×	24	330
Ramon Saccilotto Switzerland	9	46 0.5×	27 0.4×	25 0.6×	35 0.9×	93 2.6×	17	310
Victoria Rotshild Israel	11	76 0.8×	154 2.5×	18 0.4×	29 0.7×	14 0.4×	14	416
Jeremy A Schafer United States	9	48 0.5×	18 0.3×	70 1.6×	53 1.3×	9 0.3×	12	304
Dawn Harper United States	8	44 0.5×	78 1.3×	15 0.3×	13 0.3×	23 0.6×	9	375
Henry Christensen Denmark	11	57 0.6×	38 0.6×	17 0.4×	35 0.9×	32 0.9×	16	338

Countries citing papers authored by А. С. Колбин

Since Specialization

Citations

This map shows the geographic impact of А. С. Колбин's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by А. С. Колбин with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites А. С. Колбин more than expected).

Fields of papers citing papers by А. С. Колбин

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by А. С. Колбин. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by А. С. Колбин. The network helps show where А. С. Колбин may publish in the future.

Co-authorship network of co-authors of А. С. Колбин

This figure shows the co-authorship network connecting the top 25 collaborators of А. С. Колбин. A scholar is included among the top collaborators of А. С. Колбин based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with А. С. Колбин. А. С. Колбин is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Колбин, А. С.. (2023). Resolution based on the results of the IV annual scientific-practical conference "Real clinical practice. Modernity and the future". SHILAP Revista de lepidopterología. 3(4). 1–8. 2 indexed citations

Колбин, А. С., et al.. (2023). Medical technologies assessment in COVID-19. HIV Infection and Immunosuppressive Disorders. 15(3). 105–115. 1 indexed citations

Колбин, А. С., et al.. (2023). Real-world clinical practice in health technology assessment: state of the art for 2022. SHILAP Revista de lepidopterología. 2(4). 1–9. 2 indexed citations

Колбин, А. С., et al.. (2023). Factors associated with adverse outcome among hospitalized patients with moderate to severe COVID-19. SHILAP Revista de lepidopterología. 34–46.

Колбин, А. С., et al.. (2023). Antimicrobial drug consumption in the Russian Federation (2008–2022): pharmacoepidemiological study. SHILAP Revista de lepidopterología. 25(4). 395–400.

Колбин, А. С.. (2022). Resolution based on the results of the III annual scientific and practical conference «Real clinical practice in a changing world. Challenges and Solutions». SHILAP Revista de lepidopterología. 2(3). 35–41. 2 indexed citations

Колбин, А. С., et al.. (2021). Socioeconomic and global burden of COVID-19. SHILAP Revista de lepidopterología. 20(1). 24–34. 5 indexed citations

Колбин, А. С., et al.. (2019). Hepatotoxicity of new oral anticoagulants: literature review. SHILAP Revista de lepidopterología. 3 indexed citations

Колбин, А. С., et al.. (2018). Analysis of effectiveness criteria in pharmacoeconomic studies of hypoglycemic drugs proposed for inclusion into the essential drug list in 2014-2016 in Russia. SHILAP Revista de lepidopterología. 1 indexed citations

10.

Колбин, А. С., et al.. (2018). Pharmacoeconomic analysis of vemurafenib and dabrafenib use in patients with inoperable or metastatic melanoma with BRAF V600 mutation. SHILAP Revista de lepidopterología. 1 indexed citations

11.

Колбин, А. С., et al.. (2018). Economic analysis of Lixisenatide in Diabetes Mellitus Type 2. SHILAP Revista de lepidopterología. 1 indexed citations

12.

Колбин, А. С., et al.. (2018). Pharmacoeconomic analysis of the use of ibrutinib in therapy of the first line of a chronic lymphocytic leukaemia for patients with 17p deletion. SHILAP Revista de lepidopterología.

13.

Климко, Н Н, С. Н. Хостелиди, А. С. Колбин, et al.. (2016). Mucormycosis in children with hematological and oncological diseases in saint-petersburg. Journal Infectology.

14.

Колбин, А. С., et al.. (2015). FIRST RUSSIAN TYPE 2 DIABETES MELLITUS SIMULATION MODEL WITH DISCREET EVENTS MODELING. HEALTH-ECONOMIC ANALYSIS. SHILAP Revista de lepidopterología. 1 indexed citations

15.

Колбин, А. С., et al.. (2015). PHARMACOECONOMIC ANALYSIS OF THE USE OF OXALIPLATIN CHEMOTHERAPY FOR COLORECTAL CANCER.REAL (ACTUAL) CLINICAL PRACTICE DATA. SHILAP Revista de lepidopterología. 2 indexed citations

16.

Климко, Н Н, С. Н. Хостелиди, Marina Popova, et al.. (2014). Invasive aspergillosis: results of multicenter study. SHILAP Revista de lepidopterología. 4 indexed citations

17.

Климко, Н Н, et al.. (2014). Successful treatment of pulmonary mucormycosis in a child with aplastic anemia. SHILAP Revista de lepidopterología. 1 indexed citations

18.

Колбин, А. С., et al.. (2011). [Clinical and economic expedience of ertapenem therapy of complicated urinary tract infection].. PubMed. 56(1-2). 35–42. 1 indexed citations

19.

Колбин, А. С., et al.. (2007). USAGE RATE OF THE UNLICENSED MEDICATIONS IN NEONATOLOGY: DATA OF THE PHARMACO EPIDEMIOLOGICAL RESEARCH. SHILAP Revista de lepidopterología. 2 indexed citations

20.

Колбин, А. С.. (2006). PHARMACOECONOMICAL EVALUATION OF INVASIVE CANDIDOSIS PREVENTION IN THE NEONATES WITH VERY LOW BODY MASS. SHILAP Revista de lepidopterología. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact